Back
Candel Therapeutics, Inc. Vs. Nebius Group NV Industry Stock Comparison
Buy
52
CADL
Candel Therapeutics, Inc.
Last Price:
$5.56
Seasonality Move:
2.55%
Sell
42
NBIS
Nebius Group NV
Last Price:
$89.47
Seasonality Move:
-2.57%
Buy
52
Candel Therapeutics, Inc. (CADL)
is a Buy
Is Candel Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Candel Therapeutics, Inc. [CADL] share price is $5.57. The Score for CADL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CADL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CADL Stock Price Chart
What is Candel Therapeutics, Inc.'s stock price today?
-
The Candel Therapeutics, Inc. share price today is $5.57The current trend is moderately bullish and CADL is experiencing slight selling pressure.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $89.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CADL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 54.34 | Buy |
| Chaikin Money Flow: | -162234 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.51 - 5.75) | Buy |
| Bollinger Bands (100): | (4.87 - 5.97) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.05 | Sell |
| Relative Strength Index (14 RSI): | 47.32 | Sell |
| Chaikin Money Flow: | 13904832 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.34 - 98.02) | Sell |
| Bollinger Bands (100): | (72.32 - 115.66) | Sell |
CADL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.84 | Sell |
| 20-day SMA: | 5.27 | Buy |
| 50-day SMA: | 5.26 | Buy |
| 200-day SMA: | 5.64 | Sell |
| 8-day EMA: | 5.64 | Sell |
| 20-day EMA: | 5.43 | Buy |
| 50-day EMA: | 5.31 | Buy |
| 200-day EMA: | 5.63 | Sell |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.08 | Buy |
| 20-day SMA: | 91.37 | Sell |
| 50-day SMA: | 102.98 | Sell |
| 200-day SMA: | 65.21 | Buy |
| 8-day EMA: | 85.42 | Buy |
| 20-day EMA: | 90.53 | Sell |
| 50-day EMA: | 95.55 | Sell |
| 200-day EMA: | 73.6 | Buy |
Candel Therapeutics, Inc. Earnings Growth & CADL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.11 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.
Candel Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||